These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 307835)
21. [The effect of Anturane and aspirin on thrombocyte aggregation]. Ciko Z; Stanimirović D Vojnosanit Pregl; 1984; 41(5):341-5. PubMed ID: 6516242 [No Abstract] [Full Text] [Related]
22. Evidence for a postsecretory reabsorptive site for uric acid in man. Diamond HS; Paolino JS J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233 [TBL] [Abstract][Full Text] [Related]
23. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
24. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone. Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772 [No Abstract] [Full Text] [Related]
25. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related]
26. Effects of sulphinpyrazone and dipyridamole on capillary bleeding time in man. Weston MJ; Rubin MH; Langley PG; Westaby S; Williams R Thromb Res; 1977 Jun; 10(6):833-40. PubMed ID: 882967 [No Abstract] [Full Text] [Related]
27. Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Mills DG; Borda IT; Philp RB; Eldridge C Clin Pharmacol Ther; 1974 Feb; 15(2):187-92. PubMed ID: 4590801 [No Abstract] [Full Text] [Related]
28. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro. Toivanen J; Ylikorkala O; Viinikka L Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778 [TBL] [Abstract][Full Text] [Related]
29. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo. Pay GF; Wallis RB; Zelaschi D Haemostasis; 1981; 10(3):165-75. PubMed ID: 7262645 [TBL] [Abstract][Full Text] [Related]
30. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Domoto DT; Bauman JE; Joist JH Thromb Res; 1991 Jun; 62(6):737-43. PubMed ID: 1926064 [TBL] [Abstract][Full Text] [Related]
31. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis. Philp RB; Francey I; Warren BA Haemostasis; 1978; 7(5):282-93. PubMed ID: 689491 [TBL] [Abstract][Full Text] [Related]
32. Mode of action of currently used antiplatelet drugs. de Gaetano G; Bertele' V; Cerletti C Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442 [No Abstract] [Full Text] [Related]
33. A study of the effect of sulphinpyrazone ('Anturan') on blood viscosity. Johnston RV; Lowe GD; Drummond MM; Forbes CD; Prentice CR Curr Med Res Opin; 1979; 6(4):271-3. PubMed ID: 527353 [TBL] [Abstract][Full Text] [Related]
34. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity. Cerletti C Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097 [TBL] [Abstract][Full Text] [Related]
35. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone. Lussier A; LeBel E Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642 [TBL] [Abstract][Full Text] [Related]
36. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. de Gaetano G; Cerletti C; Bertelè V Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469 [No Abstract] [Full Text] [Related]
37. Sulphinpyrazone increases lymphocyte beta-adrenoceptors in man. De Blasi A; Cotecchia S Br J Clin Pharmacol; 1984 Dec; 18(6):963-4. PubMed ID: 6099136 [No Abstract] [Full Text] [Related]